Instrument Inactif

Gouvernance Osiris Therapeutics, Inc.

US68827R1086

Recherche biotechnologique et médicale

Comité Exécutif: Osiris Therapeutics, Inc.

Dirigeant

Fonctions occupéesDepuis

Heather Hill

General Counsel

01/01/2007

Jeffrey Levin

Human Resources Officer

01/11/2018

Composition du Conseil d'Administration: Osiris Therapeutics, Inc.

Administrateur	ComitésDepuis

Anciens Dirigeants et Administrateurs: Osiris Therapeutics, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Peter A. Friedli

Chairman	23/12/1992	17/04/2019
Founder	23/12/1992	17/04/2019

Thomas Knapp

Director/Board Member	07/02/2017	17/04/2019
Independent Dir/Board Member	07/02/2017	17/04/2019

Alla Danilkovitch

Chief Tech/Sci/R&D Officer

01/04/2003

17/04/2019

Jason Keefer

Chief Executive Officer	09/02/2018	26/11/2018
Corporate Officer/Principal	26/11/2018	17/04/2019
President	01/02/2018	26/11/2018
Sales & Marketing	01/08/2016	26/11/2018

Moya M. Daniels

Corporate Officer/Principal

01/01/2017

01/01/2019

Uwe Sommer

Director/Board Member	07/02/2017	11/09/2018
Independent Dir/Board Member	07/02/2017	11/09/2018

David L. White

Director/Board Member	30/05/2017	07/09/2018
Independent Dir/Board Member	30/05/2017	07/09/2018

Thomas M. Brandt

Director/Board Member	03/03/2016	26/06/2018
Independent Dir/Board Member	03/03/2016	26/06/2018

Linda L. Chang

Director of Finance/CFO

17/05/2017

09/05/2018

Jay Moyes

Director/Board Member	01/05/2006	13/12/2017
Independent Dir/Board Member	01/05/2006	13/12/2017

David A. Dresner

Chief Executive Officer	09/06/2016	21/06/2017
President	09/06/2016	21/06/2017

Gregory I. Law

Comptroller/Controller/Auditor	01/11/2014	17/09/2015
Director of Finance/CFO	17/09/2015	17/05/2017
Corporate Secretary	17/09/2015	17/05/2017
Treasurer	17/09/2015	17/05/2017

Rodrigo Alberto Avendano

Chief Tech/Sci/R&D Officer

03/10/2016

27/01/2017

Hans Klingemann

Director/Board Member	19/09/2012	11/06/2016
Independent Dir/Board Member	19/09/2012	11/06/2016

Bobby Dwayne Montgomery

Director/Board Member	03/03/2016	09/06/2016
Chief Executive Officer	03/02/2016	09/06/2016
Corporate Officer/Principal	25/04/2014	03/02/2016
President	03/03/2016	09/06/2016

Jonathan Hopper

Chief Tech/Sci/R&D Officer

24/11/2014

12/04/2016

Frank Czworka

Chief Operating Officer	03/02/2016	06/03/2016
Corporate Officer/Principal	01/08/2011	-

Lode Debrabandere

Director/Board Member	01/07/2006	03/02/2016
Chief Executive Officer	02/12/2013	03/02/2016
Chief Operating Officer	26/10/2012	01/11/2013
Corporate Officer/Principal	01/07/2006	26/10/2012
President	02/12/2013	03/02/2016

Therésa K. Dixon

Corporate Officer/Principal

01/03/2014

01/02/2016

Felix Gutzwiller

Director/Board Member	01/01/2003	10/06/2015
Independent Dir/Board Member	01/01/2003	10/06/2015

Yves Huwyler

Director/Board Member	01/01/2015	-
Independent Dir/Board Member	01/01/2015	-

Adrian P. Mollo

General Counsel

04/12/2014

Matthew Paul Neumayer

Comptroller/Controller/Auditor

24/11/2009

30/09/2014

Michelle Williams

Chief Tech/Sci/R&D Officer	06/11/2009	15/04/2014
Corporate Officer/Principal	01/10/2001	06/11/2009

Charles Mills

Director/Board Member	01/06/2011	02/12/2013
Chief Executive Officer	01/06/2004	02/12/2013
President	01/06/2004	02/12/2013

Stephen W. Potter

Chief Operating Officer

07/02/2011

01/11/2012

Gregory H. Barnhill

Director/Board Member	09/07/2009	14/09/2012
Independent Dir/Board Member	01/08/2006	14/09/2012

Rich W. Hunt

Director of Finance/CFO

30/09/2009

Harry E. Carmitchel

Chief Operating Officer

01/09/2004

15/07/2009

Douglas Jacobstein

Chief Tech/Sci/R&D Officer

03/06/2010

Earl Fender

Corporate Officer/Principal

01/06/2006

23/04/2008

Christopher R. Alder

General Counsel	15/05/2012	-
Corporate Officer/Principal	03/06/2010	15/05/2012

Cary Claiborne

Director of Finance/CFO	01/12/2004	01/01/2007
Corporate Secretary	01/12/2004	01/01/2007

Philip R. Jacoby

Comptroller/Controller/Auditor	17/09/2015	-
Director of Finance/CFO	14/09/2009	17/09/2015
Corporate Secretary	09/07/2009	17/09/2015
Treasurer	01/10/2005	17/09/2015

Alastair M. Mackay

Corporate Officer/Principal

31/12/2004

Mehmet C. Oz

Director/Board Member

01/01/2003

01/01/2005

Norman W. Barton

Chief Tech/Sci/R&D Officer

01/09/2002

01/04/2004

Jim C. Williams

General Counsel

01/08/2003

01/02/2004

Donald W. Fallon

Director of Finance/CFO

01/05/2002

01/12/2003

Rodney L. Monroy

Director/Board Member

01/02/2003

Katherine Turner

Corporate Officer/Principal

02/01/2002

Alan K. Smith

Chief Operating Officer	01/01/2000	01/01/2002
Chief Tech/Sci/R&D Officer	01/01/2000	01/01/2002

Robert J. Deans

Chief Tech/Sci/R&D Officer

01/01/1998

01/01/2001

Daniel Marshak

Chief Tech/Sci/R&D Officer

01/01/1994

01/01/2000

Linda Liu

Corporate Officer/Principal

01/01/1999

01/01/2000

Jim Burns

Chief Executive Officer	23/12/1992	01/01/1999
Chairman	23/12/1992	01/01/1999
Founder	23/12/1992	01/01/1999
President	23/12/1992	01/01/1999

Annemarie B. Moseley

Chief Executive Officer

Erica Elchin

Investor Relations Contact	-	-
Public Communications Contact	09/07/2009	-

Jesus Soriano

Corporate Officer/Principal

Kevin R. McIntosh

Corporate Officer/Principal

Kenneth Ray Moseley

Corporate Officer/Principal

Richard J. Kowalski

Corporate Officer/Principal

Manas K. Majumdar

Corporate Officer/Principal

Alan Musso

Director of Finance/CFO

Aziz Ahmad

Investor Relations Contact

Stewart Craig

Chief Operating Officer

Sudha Kadiyala

Corporate Officer/Principal

William H. Pursley

President

Amanda Badillo

Investor Relations Contact	-	-
Public Communications Contact	-	-

Scott Bruder

Corporate Officer/Principal

Thomas E. McDonald

Comptroller/Controller/Auditor

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	1
Femme	2

Dont comité exécutif

Homme	1
Femme	1

Dont Administrateurs

Homme	0
Femme	0

Osiris Therapeutics, Inc. est une société de médecine cellulaire et régénérative. La société se concentre sur la recherche, le développement et la commercialisation de produits sur les marchés du traitement des plaies, de l'orthopédie et de la médecine sportive. La société opère par le biais de son secteur d'activité Biochirurgie, qui se concentre sur les produits destinés au traitement des plaies, à l'orthopédie et à la médecine sportive, afin d'exploiter la capacité des cellules et des nouvelles constructions à favoriser la guérison naturelle du corps. Les produits de la société comprennent Grafix, Stravix, TruSkin, Cartiform et BIO4. La société produit et distribue Grafix pour les plaies aiguës et chroniques, Stravix pour la réparation des tendons, TruSkin pour la fermeture des plaies, Cartiform, un filet de cartilage viable pour la réparation du cartilage, et BIO4 pour la croissance osseuse. Le procédé de cryoconservation BioSmart de la société permet de conserver les caractéristiques natives et la fonctionnalité inhérente des tissus. Son procédé BioSmart comprend la préservation de la matrice tridimensionnelle (3D), des facteurs de croissance endogènes et des cellules résidant dans les tissus.

Employés

Secteur

Recherche biotechnologique et médicale

Plus d'informations sur la société